BR112012007642A2 - "composições líquidas precursoras para tratamento de difusões orais com ph-dependente de liberação sustentada e respectivo uso" - Google Patents

"composições líquidas precursoras para tratamento de difusões orais com ph-dependente de liberação sustentada e respectivo uso"

Info

Publication number
BR112012007642A2
BR112012007642A2 BR112012007642A BR112012007642A BR112012007642A2 BR 112012007642 A2 BR112012007642 A2 BR 112012007642A2 BR 112012007642 A BR112012007642 A BR 112012007642A BR 112012007642 A BR112012007642 A BR 112012007642A BR 112012007642 A2 BR112012007642 A2 BR 112012007642A2
Authority
BR
Brazil
Prior art keywords
diffusions
treatment
sustained release
liquid compositions
precursor liquid
Prior art date
Application number
BR112012007642A
Other languages
English (en)
Inventor
Friedman Michael
Gati Irith
Steinberg Doron
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Publication of BR112012007642A2 publication Critical patent/BR112012007642A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/31—Anhydrous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/594—Mixtures of polymers
BR112012007642A 2009-10-05 2010-10-05 "composições líquidas precursoras para tratamento de difusões orais com ph-dependente de liberação sustentada e respectivo uso" BR112012007642A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24854409P 2009-10-05 2009-10-05
PCT/IL2010/000808 WO2011042897A1 (en) 2009-10-05 2010-10-05 Liquid precursor compositions and uses thereof for a ph-dependant sustained release treatment of oral disorders

Publications (1)

Publication Number Publication Date
BR112012007642A2 true BR112012007642A2 (pt) 2016-08-09

Family

ID=43568292

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012007642A BR112012007642A2 (pt) 2009-10-05 2010-10-05 "composições líquidas precursoras para tratamento de difusões orais com ph-dependente de liberação sustentada e respectivo uso"

Country Status (6)

Country Link
US (1) US10843013B2 (pt)
EP (1) EP2485713B1 (pt)
CN (1) CN102724963B (pt)
BR (1) BR112012007642A2 (pt)
MX (1) MX2012003986A (pt)
WO (1) WO2011042897A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101801521B (zh) 2007-05-14 2015-06-17 纽约州立大学研究基金会 生物膜中细菌细胞内的生理学分散响应诱导
EP2691085A1 (en) * 2011-03-29 2014-02-05 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Film-forming composition for a ph-dependant sustained release of the active agent
RU2577304C2 (ru) * 2011-11-07 2016-03-10 Колгейт-Палмолив Компани Пленкообразующие композиции для зубов
CN102846386B (zh) * 2012-09-19 2015-02-25 四川大学 智能可控释放抗菌成分的牙种植体及制备方法
RU2646501C2 (ru) * 2013-09-11 2018-03-05 3М Инновейтив Пропертиз Компани Композиции для полости рта
CN108472251B (zh) * 2016-01-13 2022-02-01 株式会社 Lg 生活健康 口腔用制剂
WO2018058199A1 (en) * 2016-09-30 2018-04-05 R.M Creighton Dental Pty Ltd Dental caries status disclosing solutions
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
CA3105187A1 (en) 2018-06-28 2020-01-02 Arx, Llc Dispensing method for producing dissolvable unit dose film constructs
CN109776873B (zh) * 2018-12-12 2020-10-27 华南理工大学 乳液溶剂挥发法制备大孔聚合物微球

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5160737A (en) * 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
US5330746A (en) 1988-05-03 1994-07-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Dental varnish composition, and method of use
US5102668A (en) 1990-10-05 1992-04-07 Kingaform Technology, Inc. Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
US6197331B1 (en) * 1997-07-24 2001-03-06 Perio Products Ltd. Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
JP2001517493A (ja) * 1997-09-26 2001-10-09 ノーヴェン ファーマシューティカルズ インコーポレイテッド 生体接着剤組成物及び活性薬剤の局所投与方法
EP2260836B1 (en) * 1998-11-25 2016-08-10 Cima Labs Inc. Rapid release tablet with coated drug-containing core and surrounding taste masking layer
US7074392B1 (en) * 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
US20070190124A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs
WO2007016315A2 (en) * 2005-07-28 2007-02-08 Dr. Reddy's Laboratories Ltd. Extended release venlafaxine compositions
GB0816365D0 (en) 2008-09-08 2008-10-15 Univ Belfast Polymeric material

Also Published As

Publication number Publication date
US10843013B2 (en) 2020-11-24
WO2011042897A1 (en) 2011-04-14
MX2012003986A (es) 2012-06-25
CN102724963A (zh) 2012-10-10
US20120288566A1 (en) 2012-11-15
CN102724963B (zh) 2015-12-16
EP2485713A1 (en) 2012-08-15
EP2485713B1 (en) 2018-09-26

Similar Documents

Publication Publication Date Title
BR112012007642A2 (pt) "composições líquidas precursoras para tratamento de difusões orais com ph-dependente de liberação sustentada e respectivo uso"
SMT201400181B (it) Composizioni per vasocostrizione e metodi d'uso
IL250435A0 (en) Using hil-2-mutein of human origin to prepare a factor for the production of regulatory t cells
BRPI1011876A2 (pt) "composição farmacêutica estável e métodos de uso da mesma"
SMT201500213B (it) Alcune triazolopirazine, loro composizioni e metodi d'uso
BR112012002331A2 (pt) composição antiviral, composição farmacêutica e uso de quantidade efetiva de composição farmacêutica
BRPI0817200A2 (pt) composições oftálmicas sólida e uso de compostos para fabricação de medicamento
IL214098A (en) Derivatives of 2– (pyrolidine – 2 – il) - h1– benzimidazole, pharmaceutical preparations containing them and their use in the preparation of drugs
BRPI0908292A2 (pt) "métodos e composições para administração oral de exenatida"
HK1139854A1 (en) Fast-dissolving disintegrating film preparation having high proportion of active agent
EP2477625A4 (en) PHARMACEUTICAL COMPOSITIONS AND FORMULATIONS COMPRISING PLECKSTRINE HOMOLOGY DOMAIN INHIBITORS AND METHODS OF USE
BR112013000705A2 (pt) "composição de limpeza para cuidado pessoal"
BRPI0915928A2 (pt) composições e métodos de uso para anticorpos terapêuticos
BRPI0807487A2 (pt) Uso de antagonistas de il-23 para o tratamento de infecção
BRPI1007675A2 (pt) "dispositivo para inalação de insumos medicinais"
BRPI0819821A2 (pt) Preparação e uso de polianilinas para tratamento de água
BR112012015392A2 (pt) "composto e uso cosmético de um composto"
IL221541A (en) A solid preparation for oral administration of colors and diagnostic use
BRPI1006040A2 (pt) uso de composições farmacêuticas, tipo de curativo médico, e, tipo de caixa de medicamento
BRPI0920355A2 (pt) composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina
BR112012029685A2 (pt) composição espumável de tratamento oral não aerada e uso de hidrofobina
BRPI0910780A2 (pt) uso de antagonistas de opióides para o tratamento da retenção urinária
BRPI1006666A2 (pt) " composição farmacêutica e uso de uma composição farmacêutica"
CO6210802A2 (es) Composicion de locion para uso personal
IT1406068B1 (it) Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B25H Request for change of headquarter rejected

Owner name: YISSUM RESEARCH DEVELOPMENT CO. OF THE HEBREW UNIV